In contrast, our study analyzed CDH17 immunoexpression in multiple histological regions—tumor core, invasive front, lymphovascular emboli, and lymph node metastases—in 84 CRC cases selected for the presence of lymphovascular invasion. The gene discussed is CDH17; the disease is neoplasm.